Literature DB >> 21831747

Probiotic lactic acid bacteria in the gastro-intestinal tract: health benefits, safety and mode of action.

L M T Dicks1, M Botes.   

Abstract

Lactic acid bacteria (LAB) have received considerable attention as probiotics over the past few years. This concept has grown from traditional dairy products to a profitable market of probiotic health supplements and functional foods. Extensive research is done on novel potential probiotic strains, with specific emphasis on their health benefits and mode of action. Criteria for the selection of probiotic strains have only recently been formulated by the Food and Agriculture Organization of the United Nations and the World Health Organization (FAO/WHO). Several in vitro techniques have been developed to evaluate the probiotic properties of strains. In many cases, this is followed by in vivo tests. Safety studies are also obligatory, as a few cases of bacteremia caused by LAB have been reported. This review focuses on the health benefits and safety of LAB probiotics, the criteria used to select a probiotic, mode of action and the impact these organisms have on natural microbiota in the gastro-intestinal tract.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21831747     DOI: 10.3920/BM2009.0012

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  47 in total

Review 1.  Reporter systems for in vivo tracking of lactic acid bacteria in animal model studies.

Authors:  Winschau F van Zyl; Shelly M Deane; Leon M T Dicks
Journal:  Gut Microbes       Date:  2015

2.  Oral administration of the lactic acid bacterium Pediococcus acidilactici attenuates atherosclerosis in mice by inducing tolerogenic dendritic cells.

Authors:  Taiji Mizoguchi; Kazuyuki Kasahara; Tomoya Yamashita; Naoto Sasaki; Keiko Yodoi; Takuya Matsumoto; Takuo Emoto; Tomohiro Hayashi; Naoki Kitano; Naofumi Yoshida; Hilman Zulkifli Amin; Ken-Ichi Hirata
Journal:  Heart Vessels       Date:  2017-02-08       Impact factor: 2.037

Review 3.  Bioengineered probiotics, a strategic approach to control enteric infections.

Authors:  Mary Anne Roshni Amalaradjou; Arun K Bhunia
Journal:  Bioengineered       Date:  2013-01-17       Impact factor: 3.269

4.  Antibiotic resistance, biochemical typing, and PFGE typing of Bifidobacterium strains commonly used in probiotic health foods.

Authors:  Feili Xu; Junping Wang; Yunchang Guo; Ping Fu; Huawei Zeng; Zhigang Li; Xiaoyan Pei; Xiumei Liu; Shuo Wang
Journal:  Food Sci Biotechnol       Date:  2018-02-12       Impact factor: 2.391

5.  A secreted bacterial peptidoglycan hydrolase enhances tolerance to enteric pathogens.

Authors:  Kavita J Rangan; Virginia A Pedicord; Yen-Chih Wang; Byungchul Kim; Yun Lu; Shai Shaham; Daniel Mucida; Howard C Hang
Journal:  Science       Date:  2016-09-22       Impact factor: 47.728

6.  Functional characterization of a mucus-specific LPXTG surface adhesin from probiotic Lactobacillus rhamnosus GG.

Authors:  Ingemar von Ossowski; Reetta Satokari; Justus Reunanen; Sarah Lebeer; Sigrid C J De Keersmaecker; Jos Vanderleyden; Willem M de Vos; Airi Palva
Journal:  Appl Environ Microbiol       Date:  2011-05-20       Impact factor: 4.792

7.  Lactobacillus equigenerosi strain Le1 invades equine epithelial cells.

Authors:  Marlie Botha; Marelize Botes; Ben Loos; Carine Smith; Leon M T Dicks
Journal:  Appl Environ Microbiol       Date:  2012-04-13       Impact factor: 4.792

8.  Exploiting a host-commensal interaction to promote intestinal barrier function and enteric pathogen tolerance.

Authors:  Virginia A Pedicord; Ainsley A K Lockhart; Kavita J Rangan; Jeffrey W Craig; Jakob Loschko; Aneta Rogoz; Howard C Hang; Daniel Mucida
Journal:  Sci Immunol       Date:  2016-09-22

9.  Mechanisms of Action of Probiotics.

Authors:  Julio Plaza-Diaz; Francisco Javier Ruiz-Ojeda; Mercedes Gil-Campos; Angel Gil
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

10.  Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 alleviated symptoms of Salmonella infection, as determined in Wistar rats challenged with Salmonella enterica serovar Typhimurium.

Authors:  Leon M T Dicks; Kim ten Doeschate
Journal:  Curr Microbiol       Date:  2010-02-02       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.